| Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations |
Globe Newswire |
11/03 |
08:00 |
| Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026 |
Globe Newswire |
11/03 |
08:00 |
| Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026 |
Globe Newswire |
11/03 |
08:00 |
| Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026 |
Globe Newswire |
11/03 |
08:00 |
| XMax Announces $30 Million Share Repurchase Program |
Globe Newswire |
11/03 |
08:00 |
| NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in November |
Globe Newswire |
11/03 |
08:00 |
| City Therapeutics to Present at Upcoming November Investor Conferences |
Globe Newswire |
11/03 |
08:00 |
| Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation |
Globe Newswire |
11/03 |
08:00 |
| Bond Announces Strategic Financial Realignment, Converting Approximately $15 Million of Debt and Preferred Stock into Equity |
Globe Newswire |
11/03 |
08:00 |
| HiBob Delivers Trusted Organizational Intelligence to Microsoft Entra for Smarter IT Workflows |
Globe Newswire |
11/03 |
08:00 |
| Septerna to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/03 |
08:00 |
| Aeries Technology to Report Second-Quarter Fiscal 2027 Results on November 5, 2026 |
Globe Newswire |
11/03 |
08:00 |
| Core Molding Technologies Reports Fiscal 2026 Third Quarter Results |
Globe Newswire |
11/03 |
08:00 |
| Bitget Records $1.86 Trillion in Q3 Trading Volume, Expands Liquidity Across Crypto and TradFi |
Globe Newswire |
11/03 |
08:00 |
| EPRI Launches AI-Power Exchange (APEX) to Advance Global Collaboration on AI for Power and Power for AI |
Globe Newswire |
11/03 |
08:00 |
| Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations |
Globe Newswire |
11/03 |
08:00 |
| IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc. |
Globe Newswire |
11/03 |
08:00 |
| Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx |
Globe Newswire |
11/03 |
08:00 |
| TENX INVESTOR NOTICE: RGRD Law Announces that Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline |
Globe Newswire |
11/03 |
08:00 |
| Nuclear News Names Deep Isolation Director of Engineering Matt Waples to 2026 “40 Under 40” List |
Globe Newswire |
11/03 |
08:00 |
| Paradise uRDN System Demonstrates 19.5 mmHg Blood Pressure Reduction at 12 Months, with Durability Through 4 Years |
Globe Newswire |
11/03 |
08:00 |
| Avalyn to Present at Upcoming Investor Conferences |
Globe Newswire |
11/03 |
08:00 |
| Melissa Enhances Global Address Verification with Address Suggestions |
Globe Newswire |
11/03 |
08:00 |
| RoyaLand (RLNDF) Celebrates Savoia Calcio’s Coppa Italia Quarter-Final Spot, a First in the Club’s 118-Year History |
Globe Newswire |
11/03 |
08:00 |
| 4DMT to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/03 |
08:00 |
